Sanne Ter Horst

Sanne Ter Horst

Auto-generated profile, based on publicly available information

Sanne Ter Horst

Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2025 in Journal of Critical Care
Verified
Journal Article
Open access
SHSanne Ter Horst
Sanne Ter Horst
RWRaymond J. van Wijk
Raymond J. van Wijk
ASAnna D. Schoonhoven
Anna D. Schoonhoven
ALAnouk de Lange
Anouk de Lange
JMJan C. ter Maaten
Jan C. ter Maaten
HBHjalmar R. Bouma
Hjalmar R. Bouma
Sepsis is a life-threatening disorder with an in-hospital mortality rate of 10-40 %. Identifying patients at risk for deterioration is critical in guiding clinical decisions for patients with infection at the emergency department (ED). While pulse oximetry is known for estimating oxygen saturation, we hypothesize that photoplethysmography (PPG) can reflect early cardiovascular changes in sepsis. This study explores the potential use of pulse oximetry - PPG as a tool for predicting clinical deterioration in patients with early sepsis. We conducted a secondary analysis of prospectively obtained data from the Acutelines data-biobank, involving 576 patients with early sepsis at the ED. Clinical and demographic data, vital signs, laboratory values, and PPG waveforms were collected. Groups were determined by a composite endpoint of intensive care unit (ICU) admission and/or in-hospital mortality within 48 h. PPG features were calculated and differences between groups were analyzed. Within our study cohort, 9.7 % of patients were admitted to the ICU and/or deceased within 48 h after ED arrival. During the first 20 min after ED arrival, patients who deteriorated showed lower systolic peak amplitude (SPA: 1218 vs. 1490 AU, p < 0.001), lower diastolic peak amplitude (DPA: 462 vs. 621 AU, p < 0.001), and shorter pulse intervals (PI: 0.540 vs. 0.609 s, p < 0.001) on PPG. Additionally, the APG b/a ratio was lower (-0.881 vs. -0.802, p < 0.001). In contrast, systolic blood pressure (SBP: 123 vs. 129 mmHg, p = 0.186), diastolic blood pressure (DBP: 78 vs. 76 mmHg, p = 0.400), mean arterial pressure (MAP: 88 vs. 95 mmHg, p = 0.111) did not differ between groups. Heart rate (HR: 111 vs. 99 bpm, p = 0.001) and PPG-derived PI were both significantly different and strongly correlated (ρ = -0.921), as both reflect the duration of one interbeat interval. This study highlights the potential use of PPG as a valuable tool for detecting early cardiovascular changes in sepsis. These findings hold significance for developing novel tools that can facilitate early identification of patients at risk for deterioration, thereby improving clinical decisions and outcomes for ED patients with early sepsis.

13 March 2026 in Journal of Critical Care
Verified
Journal Article
Open access
SHSanne Ter Horst
Sanne Ter Horst
JOJochem van Oosten
Jochem van Oosten
RLRanek Laros
Ranek Laros
BSBashar Sukkar
Bashar Sukkar
JEJildou van Everdink
Jildou van Everdink
TOTycho J. Olgers
Tycho J. Olgers
Initial fluid resuscitation is central to sepsis management, yet excessive fluids may exceed a patient's fluid tolerance, increasing the risk of fluid overload and organ dysfunction. The Venous Excess Ultrasound (VExUS) score allows noninvasive bedside assessment of venous congestion, but its prevalence and predictive value in the emergency department (ED) are unclear. We analyzed prospectively collected data from the Acutelines data-biobank (University Medical Center Groningen, Netherlands). Adults with suspected sepsis requiring initial fluid resuscitation underwent VExUS assessments, including inferior vena cava and organ-specific Doppler measurements, within three hours of ED admission. The primary outcome was clinical fluid overload within 72 h, defined as positive fluid balance plus ≥10% weight gain, pulmonary edema on imaging, or loop diuretic use. Associations were analyzed using logistic and mixed-effects regression. Among 103 patients, 34 (33%) developed clinical fluid overload. At ED admission, 75% had VExUS grade 0, 22% grade 1, and 3% grade ≥ 2. At baseline, VExUS>0 and abnormal hepatic venous Doppler flow were associated with fluid overload within 72 h (aOR 3.66, 95% CI 1.23-11.55; p = 0.022 and 4.20, 95% CI 1.21-16.38; p = 0.028, respectively). In repeated-measures analyses, VExUS>0 and abnormal intrarenal venous Doppler flow were associated with next-day fluid overload. In patients with suspected sepsis, mild venous congestion was independently associated with clinical fluid overload within 72 h. Abnormal hepatic and intrarenal flow patterns may provide additional information on venous congestion. Early, serial VExUS assessments may detect fluid intolerance and support individualized fluid management.

9 September 2025 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
SHSanne Ter Horst
Sanne Ter Horst
ASAnna D. Schoonhoven
Anna D. Schoonhoven
RWRaymond J. van Wijk
Raymond J. van Wijk
RWRick Weitering
Rick Weitering
SLSanne W. van Loon
Sanne W. van Loon
HBHjalmar R. Bouma
Hjalmar R. Bouma
Introduction: Sepsis remains a leading cause of mortality, with mortality from septic shock exceeding 40%. Standardized resuscitation (30 mL/kg) may cause adverse outcomes, including fluid overload or prolonged hypotension, emphasizing the need for individualized strategies. Sepsis‐induced shock arises from varying degrees of vasodilation and hypovolemia, yet patients often present with similar clinical signs in the emergency department (ED). Photoplethysmography (PPG), a non‐invasive technique reflecting peripheral perfusion, may help identify patients with a predominant vasodilatory profile who could benefit from early vasopressor therapy.Methods: This post hoc analysis used data from the Acutelines biobank at the University Medical Centre Groningen. Adults admitted for non‐trauma specialties with suspected infection and hemodynamic instability (MAP < 70 mmHg, SBP < 90 mmHg, shock index > 0.9, or lactate > 4.0 mmol/L) were included. PPG data were pre‐processed and features extracted. Principal component analysis (PCA) and K‐means clustering enabled dimensionality reduction and hemodynamic profiling. Logistic regression assessed the discriminative performance of PPG‐based models for vasopressor therapy initiation within 24 h.Results: Among 325 patients, 16.3% received vasopressors. PCA identified three principal components explaining 80.3% of variance: PC1 (arterial compliance), PC2 (cardiac output and systemic vascular resistance), and PC3 (peripheral vasomotor tone). The PPG‐based model showed moderate discriminative power (AUROC: 0.75), improving when combined with MAP and lactate (AUROC: 0.83).Conclusion: PPG enables identification of patients likely to benefit from vasopressor therapy during the first 20 min after ED arrival. By providing additional insight into peripheral perfusion, this proof‐of‐principle study supports further exploration of PPG as a clinical support tool for personalized hemodynamic resuscitation in sepsis.Editorial Comment: This secondary analysis demonstrates early peripheral circulatory patterns in sepsis using photoplethysmography at the start of resuscitation. Distinct PPG‐derived profiles were associated with vasopressor initiation within 24 h, supporting PPG as a tool for personalized resuscitation.

9 June 2025 in Critical Care Explorations
Verified
Journal Article
Open access
SHSanne Ter Horst
Sanne Ter Horst
JMJan C. ter Maaten
Jan C. ter Maaten
MMMatijs van Meurs
Matijs van Meurs
JMJill Moser
Jill Moser
Hjalmar R. BoumaHjalmar R. Bouma
Hjalmar R. Bouma
Sepsis is a dysregulated, potentially fatal host response to infection, characterized by heterogeneity in clinical presentation and organ failure mechanisms. Early hemodynamic resuscitation and antibiotics are crucial treatments. Current guidelines recommend a one-size-fits-all approach of 30 mL/kg fluids, which may worsen vascular leakage and organ dysfunction in some patients. Personalized strategies using biomarkers and dynamic fluid responsiveness assessments offer a more tailored approach, potentially preventing fluid overload while ensuring perfusion. A recent multiomics analysis identified sepsis subgroups benefiting from either liberal or restrictive fluid resuscitation, highlighting -omics’ potential in personalized fluid management and the role of immune regulation and endothelial dysfunction in septic shock. Despite progress, methodological challenges hinder clinical implementation of biomarkers. Addressing issues like rapid point-of-care biomarker assays already at emergency department or ICU admission, standardizing sepsis diagnosis, robust external validation, and clinical trial enrichment is crucial for advancing biomarker-guided fluid management in clinical settings.

8 July 2026 in Internal and Emergency Medicine
Verified
Journal Article
Open access
PDF file
MVMichèle A. ter Voert
Michèle A. ter Voert
JLJingyi Lu
Jingyi Lu
CHCarolina Hincapié-Osorno
Carolina Hincapié-Osorno
TATamar J. van der Aart
Tamar J. van der Aart
SHSanne Ter Horst
Sanne Ter Horst
Hjalmar R. BoumaHjalmar R. Bouma
Hjalmar R. Bouma
Early sepsis recognition is challenging due to its heterogeneous presentations and limited rapid diagnostic and prognostic tools. The TriVerity TM Test, a high-multiplex host-response mRNA point-of-care test, supports clinical decision-making by estimating infection likelihood and illness severity. This study assesses TriVerity’s accuracy in Dutch emergency department (ED) patients. Adult ED patients with suspected infection and Systemic Inflammatory Response Syndrome score (SIRS) ≥2 or quick Sequential Organ Failure Assessment (qSOFA) ≥2 were prospectively included by the Acutelines data/biobank. The TriVerity test provides three scores: likelihood of bacterial infection, viral infection, and illness severity. Infection status was determined post hoc by independent physicians through clinical consensus and forced adjudication. Illness severity was defined as ICU admission or death within 7 days after ED admission. Among the 467 patients included, 234 (50%) had a bacterial infection, 80 (17%) had a viral infection, 86 (18%) had a bacterial–viral co-infection, and 67 (14%) had no infection. For bacterial infections, the TriVerity assay demonstrated a rule-in specificity of 89–94% and a rule-out sensitivity of 87–92%, depending on the adjudication method (forced vs. consensus). For viral infections, the rule-in specificity was 92–95%, and the rule-out sensitivity ranged from 76 to 92%. The illness severity score showed a rule-in specificity of 83–86% and a rule-out sensitivity of 85–87%. The TriVerity test demonstrated high specificity and sensitivity for both bacterial and viral infections, with high sensitivity and modest positive predictive value in identifying patients at risk of developing severe illness.

19 December 2025 in PLOS ONE
Verified
Journal Article
Open access
SHSanne Ter Horst
Sanne Ter Horst
EAEwoud ter Avest
Ewoud ter Avest
JEJildou van Everdink
Jildou van Everdink
MMMatijs van Meurs
Matijs van Meurs
TOTycho J. Olgers
Tycho J. Olgers
HBHjalmar R. Bouma
Hjalmar R. Bouma
Introduction: Early septic shock results from complex hemodynamic disturbances, including vasodilation, capillary leakage, and hypovolemia, requiring timely resuscitation to prevent organ failure. Initial fluid administration in the emergency department (ED) varies widely, influenced by clinician experience, patient comorbidities, and infection source. Fluid therapy is frequently not tailored to individual patient responsiveness and tolerance, highlighting the importance of personalized resuscitation strategies. Objective: This study evaluates the effectiveness of a personalized hemodynamic resuscitation strategy during the initial management of sepsis in the ED, using continuous non-invasive stroke volume index (SVI) measurements to guide intravenous (IV) fluid therapy and early vasopressor initiation. Method: This single-centre, open-label, randomized clinical trial at the Emergency Department of the University Medical Centre Groningen, the Netherlands, will enroll 188 adults with suspected sepsis requiring hemodynamic resuscitation, defined by a mean arterial pressure (MAP) <70 mmHg, systolic blood pressure (SBP) 0.9, or lactate concentration >4.0 mmol/L. Deferred consent will be obtained within 30 days of ED presentation. Patients will be randomized to the intervention group, in which fluids and vasopressors will be guided by changes in SVI (ΔSVI) after IV fluid administration, or to the control group, where fluids and vasopressors will be administered at the discretion of the treating physician during the initial 3-hour resuscitation phase. The primary endpoint is the volume of IV fluids administered within the first three hours after enrollment. Secondary endpoints include cumulative fluid balance, timing and dose of vasopressors, incidence of organ failure, hospital length of stay, mortality and fluid-related adverse events, including venous congestion assessed by point-of-care ultrasound. Expected results: We anticipate that SVI-guided resuscitation will reduce IV fluid volume compared to standard care. This personalized approach, tailoring fluid and vasopressor administration to the individual’s hemodynamic needs, has the potential to improve outcomes for patients with sepsis. Trial registration: ClinicalTrials.gov NCT07009665